Report from the European Congress of Clinical Microbiology and Infectious Diseases.
With its cool climate, Finland has a lower prevalence of fungal infections than many other European countries that have hosted the annual congress of the European Society of Clinical Microbiology and Infectious Diseases. However, changing patterns of infection and drug resistance, and their impact on treatment decisions, are as important to Nordic infectious disease specialists as to their colleagues in warmer countries. Similarly, developments in diagnostic techniques that enable fungal invasion to be identified before there is clinical evidence of infection will be a major step forward for physicians wherever they practise. It should therefore come as no surprise that this year's European Congress of Clinical Microbiology and Infectious Diseases was as well attended as previous meetings, with over 8000 participants arriving from all parts of Europe.
Anttila
Veli-Jukka
VJ
Infection Epidemiological Unit, Helsinki University Hospital, Finland. veli-jukka.anttila@hus.fi
Bryan
Jenny
J
D035843:Biomedical Research / Q000639:trends*; D019411:Clinical Laboratory Techniques / Q000379:methods*; D003141:Communicable Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D019937:Diagnostic Techniques and Procedures; D005387:Finland; D006801:Humans; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*